Shandong
China
Shandong First Medical University - Shandong Cancer Hospital and Institute
Osimertinib, Chemoradiotherapy, China, EGFR-mutated
CD24, Immune Checkpoint, Radiotherapy, Abscopal Effect, Macrophages, NSCLC, CCL2